219 related articles for article (PubMed ID: 10640987)
1. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
Bukholm IK; Nesland JM; Børresen-Dale AL
J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
Hiscox S; Jiang WG
Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
[TBL] [Abstract][Full Text] [Related]
6. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
[TBL] [Abstract][Full Text] [Related]
11. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of beta-catenin in in situ and invasive breast cancer.
Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
[TBL] [Abstract][Full Text] [Related]
13. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
15. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
16. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
17. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.
Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y
Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma.
Hao X; Palazzo JP; Ilyas M; Tomlinson I; Talbot IC
Anticancer Res; 1997; 17(3C):2241-7. PubMed ID: 9216695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
